Cue Health, a health technology company, priced its IPO of 12.5 million shares at $16 per share, for gross proceeds of $200 million, before deducting underwriting discounts and commissions and other offering expenses.
Cue Health’s stock begins trading today on the Nasdaq under HLTH The offering is expected to close Sept. 28.
The underwriters have an option to purchase up to 1.875 million additional shares at the IPO price.
Goldman Sachs, Morgan Stanley and Cowen are lead book-runners for the offering. BTIG is lead manager. Read more.
